Toward safer processes for C-C biaryl bond construction: Catalytic direct C-H arylation and tin-free radical coupling in the synthesis of pyrazolophenanthridines

Journal of Organic Chemistry

Volumn 75, Issue 2, 2010, Pages 434-441

  Hernández, Susana ^a   Moreno, Isabel ^a   SanMartin, Raul ^a   Gómez, Germán ^a   Herrero, María Teresa ^a   Domínguez, Esther ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLATIONS; BOND FORMATION; C-H ACTIVATION; CELECOXIB; CHEMICAL EQUATIONS; ENAMINONES; HETEROGENEOUS CATALYST; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHENANTHRIDINE; POLYMER-SUPPORTED; RADICAL COUPLING; RADICAL PROCESS; REGIOSELECTIVE PREPARATION;

ACTIVATION ANALYSIS; CHEMICAL BONDS; FREE RADICALS; SYNTHESIS (CHEMICAL); TIN; TITANIUM COMPOUNDS;

AROMATIC COMPOUNDS;

CARBON; FREE RADICAL; HYDROGEN; PHENANTHRIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRAZOLO[1,5 F]PHENANTHRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ARYLATION; CATALYSIS; CATALYST; CHEMICAL STRUCTURE; COVALENT BOND; CYCLIZATION; REACTION ANALYSIS; STRUCTURE ANALYSIS; SYNTHESIS;

AMINES; CATALYSIS; CYCLIZATION; FREE RADICALS; HETEROCYCLIC COMPOUNDS; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHENANTHRIDINES; STEREOISOMERISM; TIN;

EID: 75349095055     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo902257j     Document Type: Article

References (103)

1. See for example: (a) Madsen, U.; Slok, F. A.; Stensbol, T. B.; Brauner-Osborn, H.; Lutzhoft, H. C.; Poulsen, M. V.; Eriksen, L.; Krogsgaard-Larsen, P. Eur. J. Med. Chem. 2000, 35, 69-76.
2. (b) Zhang, J.; Didierlaurent, S.; Fortin, M.; Lefrancois, D.; Uridat, E.; Vevert, J. P. Bioorg. Med. Chem. Lett. 2000, 10, 1351-1355.
3. (c) Mansour, A. K.; Eid, M. M.; Khalil, N. S. A. M. Molecules 2003, 8, 744-755.
4. (d) Abunada, N. M.; Hassaneen, H. H.; Kandile, N. G.; Miqdad, O. A. Molecules 2008, 13, 1501-1517.
5. See for example: (a) Lamberth, C. Heterocycles 2007, 71, 1467-1502.
6. (b) Zheng, W.; Yates, S. R.; Papiernik, S. K. J. Agric. Food Chem. 2008, 56, 7367-7372.
7. Diaryl heterocycles in general are a selective class of COX-2 inhibitors: Chavatte, P.; Yous, S.; Marot, C.; Baurin, N.; Lesieur, D. J. Med. Chem. 2001, 44, 3223-3230.
8. (a) O'Connor, J. P.; Lysz, T. Drugs Today 2008, 44, 693-709.
9. (b) Taeuber, U. Drugs Exp. Clin. Res. 1990, 16, 7-15.
10. (c) Argentieri, D.; Ritchi, D.; Tolman, E.; Ferro, M.; Watcher, M.; Mezick, J.; Capetola, R. FASEB J. Antiinflammatory Agents, 2, 4, A369, 1988.
11. (d) Murray, W. V.; Hadden, S. K. J. Org. Chem. 1992, 57, 6662-6663.
12. (e) Habeeb, A. G.; Praveen, P. N.; Knaus, E. E. J. Med. Chem. 2001, 44, 3039-3042.
13. (f) Liu, H.; Huang, X.; Shen, J. M.; Luo, X.; Li, M.; Xiong, B.; Chen., G.; Shen, J.; Yang, Y.; Jiang, H.; Chen., K. J. Med. Chem. 2002, 45, 4816-4827.
14. (g) Singh, S. K.; Vobbalareddy, S.; Shivaramakrishna, S.; Krishnamraju, A.; Rajjak, S. A.; Casturi, S. R.; Akhila, V.; Rao, Y. K. Bioorg. Med. Chem. Lett. 2004, 14, 1683-1688.
15. (h) Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Sapuran, C. T.; Scozzafava, A.; Klebe, G. J. Med. Chem. 2004, 47, 550-557.
16. DPC602, another 1,5-disubstituted pyrazole derivative, has been used as a powerful and orally bioavailable Xa factor inhibitor: Pruitt, J. R.; Pinto, D. J. P.; Galemmo, R. A.; Alexander, R. S.; Rossi, K. A.; Wells, B. L.; Drummond, S.; Bostrom, L. L.; Burdick, D.; Bruckner, R.; Chen, H.; Smallwood, A.; Wong, P. C.; Wright, M. R.; Bai, S.; Luettgen, J. M.; Knabb, R. M.; Lam, P. Y. S.; Wexler, R. R. J. Med. Chem. 2003, 46, 5298-5315.
17. Other applications of celecoxib include the treatment of preterm labor, osteoarthritis and rheumatoid arthritis, inflammatory bowel disease, and duodenal polyposis in familial adenomatous polposis. See: (a) Stika, C. S.; Gross, G. A.; Leguizamon, G.; Gerber, S.; Levy, R.; Mathur, A.; Bernhard, L. M.; Nelson, D. M.; Sadovsky, Y. Am. J. Obstet. Gynecol. 2002, 187, 653-660.
18. (b) Dilger, K.; Herrlinger, C.; Peters, J.; Seyberth, H. W.; Scheweer, H.; Klotz, U. J. Clin. Pharmacol. 2002, 42, 985-994.
19. (c) Woessner, K. M.; Simon, R: A.; Stevenson, D. D. Arthritis Rheum. 2002, 46, 2201-2206.
20. 1-selective cannabinoid antagonist: (a) Francisco, M. E. Y.; Burgués, J. P.; George, C.; Bailey, G. S.; William, A. F.; Seltzman, H. H.; Thomas, B. F. Magn. Reson. Chem. 2003, 41, 265-268.
21. See also: (b) Kelsey, J.; Harris, O.; Cassin, J. Behav. Brain Res. 2009, 203, 304-307.
22. (a) Abet, V.; Núñez, A.; Mendicuti, F.; Burgos, C.; Alvarez-Builla, J. J. Org. Chem. 2008, 73, 8800-8807.
23. (b) Gibson, L. C. D.; Hastings, S. F.; McPhee, I.; Clayton, R. A.; Darroch, C. E.; Mackenzie, A.; Mackenzie, F. L.; Nagasawa, M.; Stevens, P. A.; MacKenzie, S. J. Eur. J. Pharmacol. 2006, 538, 39-42.
24. (c) Hutchinson, M. R.; Lewis, S. S.; Coats, B. D.; Skyba, D. A.; Crysdale, N. Y.; Berkelhammer, D. L.; Brzeski, A.; Northcutt, A.; Vietz, C. M.; Judd, C. M.; Maier, S. F.; Watkins, L. R.; Johnson, K. W. Brain Behav., Immun. 2009, 23, 240-250.
25. (a) Löber, S.; Hüber, H.; Utz, W.; Gmeiner, P. J. Med. Chem. 2001, 44, 2691-2694.
26. (b) Löber, S.; Ortner, B.; Bettinetti, L.; Hübner, H.; Gmeiner, P. Tetrahedron: Asymmetry 2002, 13, 2303-2310.
27. (c) Löber, S.; Aboul-Fadl, T.; Hübner, H.; Gmeiner, P. Bioorg. Med. Chem. Lett. 2002, 12, 633-636.
28. Phenanthridine-fused heterocycles have attracted much attention mainly due to their electroluminiscent properties which make them a material suitable for discotic liquid crystals, single and multilayer devices, and organic diodes. See for example: (a) Twieg, R. J.; Gu, S.; Semyonov, A.; Sukhomlinova, L.; Malliaras, G. G.; Fan, R.; Singer, K.; Ostroverkhova, O.; Shiyanovskaya, I. Polym. Mater.: Sci. Eng. 2000, 83, 210-211.
29. (b) Han, Y. S.; Kim, S. D.; Kwon, Y.; Choi, K.-H.; Park, L. S. Mol. Cryst. Liq. Cryst. 2006, 459, 119-128.
30. (a) Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A. M.; Diana, P.; Grimaudo, S. Farmaco 1995, 50, 365-368.
31. (b) Vrba, J.; Dolezel, P.; Vicar, J.; Ulrichova J. Toxicol. in Vitro 2009, 23, 580-588.
32. (c) Toyoda, E.; Kagaya, S.; Cowell, I. G.; Kurosawa, A.; Kamoshita, K.; Nishikawa, K.; Iiizumi, S.; Koyama, H.; Austin, C. A.; Adachi, N. J. Biol. Chem. 2008, 283, 23711-23720.
33. (a) Miyaura, N.; Yamada, K.; Suzuki, A. Tetrahedron Lett. 1979, 20, 3437-3440.
34. (b) Miyaura, N.; Suzuki, A. J. Chem. Soc., Chem. Commun. 1979, 866-867.
35. Selected reviews in: (a) Miyaura, N. Top. Curr. Chem. 2002, 219, 11-59.
36. (b) Kotha, S.; Lahiri, K.; Kashinath, D. Tetrahedron 2002, 58, 9633-9695.
37. (c) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457-2483.
38. (d) Felpin, F.-X.; Ayad, T.; Mitra, S. Eur. J. Org. Chem. 2006, 2679-2690.
39. (a) Negishi, E.; Okukado, N.; Lovich, S. F.; Luo, F. T. J. Org. Chem. 1984, 49, 2629-2632.
40. (b) Negishi, E.-I.; Anastasia, L. Chem. Rev. 2003, 103, 1979-2017.
41. Farina, V.; Krishanamurthy, V.; Scott, W. J. The Stille Reaction; Wiley: New York, 1998.
42. (a) Hiyama, T.; Hatanaka, Y. Pure Appl. Chem. 1994, 66, 1471-1478.
43. (b) Hiyama, T.; Shirakawa, E. Top. Curr. Chem. 2002, 219, 61-85.
44. (c) Denmark, S. E.; Ober, M. H. Aldrichim. Acta 2003, 36, 75-85.
45. Hydrazines 5j-m were easily prepared by a diazotization/reduction sequence starting from the corresponding anilines. For experimental details see the Supporting Information.
46. This tandem has been successfully applied by our group to the synthesis of different heterocycles: (a) Olivera, R.; SanMartin, R.; Domínguez, E.; Solans, X.; Urtiaga, M. K.; Arriortúa, M. I. J. Org. Chem. 2000, 65, 6398-6411.
47. (b) Olivera, R.; SanMartin, R.; Domínguez, E. J. Org. Chem. 2000, 65, 7010-7019.
48. (c) Olivera, R.; SanMartin, R.; Churruca, F.; Domínguez, E. J. Org. Chem. 2002, 67, 7215-7225.
49. (d) Olivera, R.; SanMartin, R.; Tellitu, I.; Domínguez, E. Tetrahedron 2002, 58, 3021-3037.
50. (e) Hernández, S.; SanMartin, R.; Tellitu, I.; Domínguez, E. Org. Lett. 2003, 5, 1095-1098.
51. For more details about the mechanism of the tandem amine exchange/heterocycization and the regioselectivity of the process with different dinucleophiles see: (a) Domínguez, E.; Ibeas, E.; Martinez de Marigorta, E.; Palacios, J. K.; SanMartin, R. J. Org. Chem. 1996, 61, 5435-5439.
52. (b) Domínguez, E.; Martínez de Marigorta, E.; Olivera, R.; SanMartin, R. Synlett 1995, 955-956.
53. Bringmann, G.; Tasler, S. Tetrahedron 2001, 57, 331-343.
54. (a) Olivera, R.; SanMartin, R.; Pascual, S.; Herrero, M.; Dominguez, E. Tetrahedron Lett. 1999, 40, 3479-3480.
55. (b) Moreno, I.; Tellitu, I.; SanMartin, R.; Badía, D.; Carrillo, L.; Domínguez, E. Tetrahedron Lett. 1999, 40, 5067-5070.
56. (c) Moreno, I.; Tellitu, I.; SanMartin, R.; Domínguez, E. Synlett 2001, 1161-1163.
57. (d) Moreno, I.; Tellitu, I.; Domínguez, E.; SanMartin, R. Eur. J. Org. Chem. 2002, 2126-2135.
58. (e) Moreno, I.; Tellitu, I.; Herrero, M. T.; SanMartin, R.; Domínguez, E. Cur. Org. Chem. 2002, 6, 1433-1452.
59. (f) Churruca, F.; SanMartin, R.; Carril, R.; Urtiaga, M. K.; Solans, X.; Tellitu, I.; Domínguez, E. J. Org. Chem. 2005, 70, 3178-3187.
60. Wang, K.; Lü, M.; Yu, A.; Zhu, X.; Wang, Q. J. Org. Chem. 2009, 74, 935-938.
61. Wang, K. L.; Wang, Q: M.; Huang, R. Q. J. Org. Chem. 2007, 72, 8416-8421.
62. Kramer, B.; Fröhlich, R.; Waldvogel, R. S. Eur. J. Org. Chem. 2003, 3549-3554.
63. Dohi, T.; Ito, M.; Morimoto, K.; Iwata, M.; Kita, Y. Angew. Chem., Int. Ed. 2008, 47, 1301-1304 and references cited therein.
64. Selected reviews: (a) Campeau, L.-C.; Fagnou, K. Chem. Commun. 2006, 1253-1264.
65. (b) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174-238.
66. (c) Ackermann, L.; Althammer, A.; Fenner, S. Angew. Chem., Int. Ed. 2009, 48, 201-204.
67. Several terms such as C-H bond activation, C-H bond functionalization, cross-dehalogenative coupling, or catalytic direct arylation have been used to identify the coupling of an aryl halide or pseudohalide with a simple arene being the former two are the most prevalent in the literature. See ref 26b. See also: (a) Bringmann, G.; Heubes, M.; Breuning, M.; Göbel, L.; Ochse, M.; Schöner, B.; Schupp, O. J. Org. Chem. 2000, 65, 722-728.
68. (b) Harayama, T.; Akiyama, T.; Nakano, Y.; Shibaike, K.; Akamatsu, H.; Hori, A.; Abe, H.; Takeuchi, Y. Synthesis 2002, 237-241.
69. (c) Daugulis, O.; Hien-Quang Do, H.-Q.; Shabashov, D. Acc. Chem. Res. 2009, 42, 1074-1086.
70. Initial results on the employment of the direct arylation of arenes under Mizoroki-Heck conditions to prepare pyrazolophenanthridines are reported in ref 18e.
71. Although the mechanism of the second step of the direct arylation is strongly dependent on several factors like the substrate, transition metal, base, solvent, and ligand, the first step is proposed to occur via oxidative addition of the transition metal into the aryl halide. This proposal is supported by the isolation of traces of the debrominated derivative.
72. For a review about the use of heterogeneous palladium catalysts in C-C coupling reactions, see: Yin, L.; Liebscher, J. Chem. Rev. 2007, 107, 133-173.
73. The FibreCat 1000 series is commercialized by Johnson Matthey Chemicals. Futher information about FibreCat catalysts, including their application in Suzuki-Miyaura and Mizoroki-Heck coupling reactions, can be found at http://www.chemicals.matthey.com.
74. Applications of this type of heterogeneous catalyst are reported in: (a) Colacot, T. J.; Gore, E. S.; Kuber, A. Organometallics 2002, 21, 3301-3304.
75. (b) Colacot, T. J. Top. Catal. 2008, 48, 91-98.
76. (c) Colacot, T. J.; Carole, W. A.; Neide, B. A.; Harad, A. Organometallics 2008, 27, 5605-4611.
77. (a) Churruca, F.; SanMartin, R.; Carril, M.; Tellitu, I.; Domínguez, E. Tetrahedron 2004, 60, 2393-2408.
78. (b) Churruca, F.; SanMartin, R.; Tellitu, I.; Dominguez, E. Eur. J. Org. Chem. 2005, 2481-2490.
79. The use of palladium supported on activated charcoal in crosscoupling reactions is described in: (a) Felpin, F.-X.; Fouquet, E.; Zakri, C. Adv. Synth. Catal. 2009, 351, 649-655.
80. (b) Felpin, F.-X.; Fouquet, E.; Zakri, C. Adv. Synth. Catal. 2008, 350, 2559-2565.
81. (c) Felpin, F.-X.; Ayad, T.; Mitra, S. Eur. J. Org. Chem. 2006, 2679-2690.
82. (d) Seki, M. Synthesis 2006, 2975-2992.
83. Reaction times longer than 3 days caused no improvement on the conversions.
84. 3CN. For more details see ref 33a. Unfortunately, ICP analysis of the filtrate after the initial filtration revealed the presence of a significant amount (>25%) of leached Pd. For a related work on the leaching of commercially available microencapsulated PdEnCat heterogeneous catalysts, see: Broadwater, S. J.; McQuade, D. T. J. Org. Chem. 2006, 71, 2131-2134.
85. (a) Narasimhan, N. S.; Aidhhen, I. S. Tetrahedron Lett. 1988, 29, 2987-2988.
86. (b) Lauk, U.; Dürst, D.; Fisher, W. Tetrahedron Lett. 1991, 32, 65-68.
87. (c) Estévez, J. C.; Villaverde, M. C.; Estévez, R. J.; Castedo, L. Tetrahedron 1993, 49, 2787-2790.
88. (d) Okita, T.; Isobe, M. Tetrahedron 1994, 50, 11143-11152.
89. (e) Estévez, J. C.; Villaverde, M. C.; Estévez, R. J.; Castedo, L. Tetrahedron 1994, 50, 2107-2114.
90. (f) Comins, D. L.; Hong, H.; Jianhua, G. Tetrahedron Lett. 1994, 35, 5331-5334.
91. (g) Suzuki, H.; Aoyagi, S.; Kibayashi, C. T. Tetrahedron Lett. 1995, 36, 5331-5334.
92. (h) Rosa, A. M.; Lob, A. M.; Branco, P. S.; Prabhakar, S.; Sá-da-Costa, M. Tetrahedron 1997, 53, 299-306.
93. (i) Couture, A.; Deniau, E.; Grandclaudon, P.; Lebrun, S. Synlett 1997, 1475-1477.
94. (j) Ho, T. C. T.; Jones, K. Tetrahedron 1997, 53, 8287-8294.
95. (k) Comins, D. L.; Thakker, P. M.; Baevsky, M. F.; Badawi, M. M. Tetrahedron 1997, 53, 16327-16340.
96. (l) Nakanishi, T.; Suzuki, M.; Mashiba, A.; Ishikawa, K.; Yokotsuka, T. J. Org. Chem. 1998, 63, 4235-4239.
97. (m) Couture, A.; Deniau, E.; Grandclaudon, P.; Hoarau, C. J. Org. Chem. 1998, 63, 3128-3132.
98. Baguley, P. A.; Walton, J. C. Angew. Chem., Int. Ed. 1998, 37, 3072-3082.
99. Sibi, M. P.; Yang, Y.-H.; Lee, S. Org. Lett. 2008, 10, 5349-5352 and references cited therein.
100. Chatgilialoglu, C. Organosilanes in Radical Chemistry; Wiley: Chichester, UK, 2004.
101. For some examples about the employment of the TTMSS/AIBN system in radical reactions see: (a) Martínez-Barrasa, V.; García de Viedma, A.; Burgos, C.; Alvarez-Builla, J. Org. Lett. 2000, 2, 3933-3935.
102. (b) Zhang, W.; Pugh, G. Tetrahedron 2003, 59, 3009-3018.
103. (c) Allin, S. M.; Bowman, W. R.; Karim, R.; Rahman, S. S. Tetrahedron 2006, 62, 4306-4316.